Voloridge Investment Management, LLC Beyond Spring Inc. Transaction History

Voloridge Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $2.66 $61,801 - $145,480	-54,692 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.68 - $5.01 $41,141 - $122,689	-24,489 Reduced 30.93%	54,692 $120,000
Q4 2021 Feb 14, 2022	SELL	$4.02 - $16.84 $416,982 - $1.75 Million	-103,727 Reduced 56.71%	79,181 $359,000
Q3 2021 Nov 15, 2021	BUY	$9.26 - $31.31 $1.69 Million - $5.73 Million	182,908 New	182,908 $2.88 Million

5.77M

53.2K

2.5K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $91.5M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.